<DOC>
	<DOCNO>NCT02497651</DOCNO>
	<brief_summary>The study aim evaluate effect smoke postprandial response plasma glucose , secretion gut - pancreatic hormone gastric empty healthy , heavy smoke men .</brief_summary>
	<brief_title>Effect Smoking Postprandial Gastric Emptying , Glucose Tolerance Secretion Gut Pancreatic Hormones</brief_title>
	<detailed_description>Epidemiological study show active smoking increase risk type 2 diabetes dose-dependent fashion . Smokers seem characterized central obesity , increase inflammatory marker oxidative stress , may lead insulin resistance irregularity glucose metabolism . The current study meal test study , aim examine number variable liquid mixed meal test ( include gastric emptying , glucose tolerance , gut pancreatic hormone response , gall bladder emptying , appetite food intake ) perform healthy non-smoking subject healthy smoker without concomitant cigarette smoking . The investigator hypothesize smoking-induced increase circulate nicotine level simultaneous activation nicotinic receptor gastrointestinal tract autonomic nervous system would detrimental effect postprandial glucose metabolism , thus , constitute important link smoking risk type 2 diabetes . The current study help clarify hypothesis improve general understand association smoke gut hormone secretion , gastric empty glucose metabolism .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Both group Caucasian ethnicity Healthy males Normal haemoglobin Age 18 year Informed write consent BMI &gt; 20 kg/m2 Smokers • Minimum 20 cigarette pr . day least 1 year Nonsmokers • No smoke regular basis Both group Diabetes prediabetes ( fast plasma glucose level &gt; 6.5 mM HbA1c &gt; 6.0 % ) First seconddegree relative diabetes Liver disease ( alanine aminotransferase ( ALAT ) and/or serum aspartate aminotransferase ( ASAT ) &gt; 2 time normal value ) history hepatobiliary disorder Gastrointestinal disease , previous intestinal resection , cholecystectomy major intraabdominal surgery Hypo hyperphosphataemia Nephropathy ( serum creatinine &gt; 150 µM and/or albuminuria Treatment medicine pause 12 hour Hypo hypercalcaemia Hypo hyperthyroidism Treatment oral anticoagulant Active recent malignant disease Any treatment condition require acute subacute medical surgical intervention Any condition consider incompatible participation investigator</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Smoking</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Incretin hormone</keyword>
	<keyword>Glucose tolerance</keyword>
</DOC>